Merck-owned StayWell has acquired Silicon Valley-based MedHelp's health engagement platform along with other assets to expand its mobile health portfolio and support its corporate growth strategy. Also, the acquisition will extend StayWell's reach to MedHelp's 3 million users, while offering more robust solutions to existing customers, during all stages of their health.
"MedHelp's innovative platform, top healthcare apps and expert team will propel StayWell's strategic company growth as we continue to expand our mobile health solutions to both new and existing markets," Nicole Latimer, CEO of StayWell, said in a statement. "The enhanced portfolio will allow us to strengthen our existing diabetes and weight management solutions, as well as enter new categories, like women's health, for the first time."
MedHelp's products include the Sugar Sense diabetes tracking app, and My Diet Diary, a calorie tracking app — both of which will be incorporated into StayWell's existing suite of diabetes management and weight loss solutions.
Also, there are My Cycles and I'm Expecting — MedHelp's ovulation and pregnancy apps — which will help StayWell enter the women's health category.
All these apps are currently available on the App Store and on Google Play. In the future, StayWell will enhance and supplement these apps as part of its comprehensive strategy.
The financial terms of the deal were not disclosed.